Protein kinase PKR is activated by double-stranded RNA (dsRNA) and phosphorylates translation initiation factor 2␣ to inhibit protein synthesis in virus-infected mammalian cells. PKR contains two dsRNA binding motifs (DRBMs I and II) required for activation by dsRNA. There is strong evidence that PKR activation requires dimerization, but the role of dsRNA in dimer formation is controversial. By making alanine substitutions predicted to remove increasing numbers of side chain contacts between the DRBMs and dsRNA, we found that dimerization of full-length PKR in yeast was impaired by the minimal combinations of mutations required to impair dsRNA binding in vitro. Mutation of Ala-67 to Glu in DRBM-I, reported to abolish dimerization without affecting dsRNA binding, destroyed both activities in our assays. By contrast, deletion of a second dimerization region that overlaps the kinase domain had no effect on PKR dimerization in yeast. Human PKR contains at least 15 autophosphorylation sites, but only Thr-446 and Thr-451 in the activation loop were found here to be critical for kinase activity in yeast. Using an antibody specific for phosphorylated Thr-451, we showed that Thr-451 phosphorylation is stimulated by dsRNA binding. Our results provide strong evidence that dsRNA binding is required for dimerization of full-length PKR molecules in vivo, leading to autophosphorylation in the activation loop and stimulation of the eIF2␣ kinase function of PKR.
The human double-stranded RNA (dsRNA) 1 -dependent protein kinase PKR is transcriptionally induced by interferon and activated in virus-infected cells by dsRNAs produced during the virus life cycle. PKR interferes with virus replication by phosphorylating the ␣ subunit of translation initiation factor 2 (eIF2␣), converting eIF2 from a substrate to an inhibitor of its guanine nucleotide exchange factor, eIF2B. This reduction in recycling of eIF2 by eIF2B leads to a general inhibition of translation that limits viral protein synthesis (1) . The yeast Saccharomyces cerevisiae harbors an eIF2␣ kinase known as GCN2 which is activated by uncharged tRNA when cells are starved for amino acids. Limited phosphorylation of eIF2␣ by GCN2 under starvation conditions leads to increased translation of GCN4 mRNA, encoding a transcriptional activator of amino acid biosynthetic genes (for review, see Ref. 2) . Low level expression of PKR in yeast produces a moderate level of eIF2␣ phosphorylation that is sufficient to induce GCN4 expression without inhibiting general protein synthesis (3) . When PKR is expressed at higher levels, eIF2␣ phosphorylation increases to the point where general translation and yeast cell growth are strongly inhibited (3, 4) .
PKR kinase activity is stimulated in vitro by dsRNA, and the N-terminal 168 amino acids of the protein contain two copies of a dsRNA-binding motif (DRBMs I and II; Fig. 1A ) that is also present in other dsRNA-binding proteins (5) . Point mutations in the DRBMs which impair dsRNA binding by PKR in vitro reduce the ability of PKR to phosphorylate eIF2␣ in yeast cells, supporting the idea that the DRBMs mediate the stimulatory effect of dsRNA on PKR kinase activity (4, 6) . dsRNA stimulates the autokinase activity of PKR (7) (8) (9) , and multiple autophosphorylation sites have been identified in the dsRNA binding and kinase domains of PKR (10 -13) . Alanine substitution of the autophosphorylation site at Thr-258 (T258A), located between the DRBMs and kinase domain, produced a modest reduction in PKR function in yeast and mammalian cells (10) . In contrast, substitution of the autophosphorylation site at Thr-446 (T446A) in the activation loop of the kinase domain substantially reduced kinase activity. The T451A mutation in the activation loop completely destroyed kinase function, but the evidence that this site is autophosphorylated was inconclusive (11) .
It has been proposed that dsRNA binding overcomes a negative effect of the DRBMs on PKR catalytic function, based on the finding that extensive deletions in the N-terminal region of the protein that removed both DRBMs did not abolish (14) , and even enhanced (15) kinase activity. The N-terminal and Cterminal halves of PKR physically interacted in the two-hybrid assay (16) , and NMR data indicate that DRBM-II, but not DRBM-I, binds to the kinase domain (17) . Additionally, dsRNA binding induces a conformational change in PKR (18, 19) .
These results have led to models in which the DRBMs (or just DRBM-II) bind to the kinase domain and interfere with its enzymatic function, and this inhibitory interaction is eliminated by a conformational change in PKR elicited by dsRNA binding to the DRBMs (17, 20) .
There is also evidence that dsRNA activates PKR by promoting dimerization of the enzyme and intermolecular autophosphorylation. The fact that PKR activation exhibits second-order kinetics with respect to protein concentration suggests that the active form of PKR is a dimer (9) , and the enzyme was purified as a phosphorylated dimer (21) . The observation that two inactive PKR alleles containing deletions of DRBM-I or DRBM-II functionally complemented was most readily explained by formation of active heterodimers (6) . It was also shown that an N-terminal segment of PKR containing the DRBMs could be coimmunoprecipitated with full-length PKR from transfected COS cells (14) , and N-terminal segments were found to interact with themselves and with full-length PKR in various interaction assays (22) (23) (24) (25) .
PKR activation is inhibited by high concentrations of dsRNA, leading to a bell-shaped dsRNA activation curve (26) . This behavior has been explained by proposing that dimerization requires binding of two PKR molecules to the same dsRNA, as high dsRNA concentrations would favor dissociation of dimers into inactive monomers bound to different dsRNA molecules (9) . Consistently, high level activation of PKR requires a minimum length of dsRNA (ϳ40 base pairs) which is considerably larger than the binding site for two DRBMs in a single PKR molecule (11-16 base pairs) (18, 27, 28) . These data, combined with the observation that PKR can autophosphorylate in trans (29, 30) , have led to the idea that binding of two PKR molecules to the same dsRNA promotes dimerization and intermolecular autophosphorylation events required for substrate phosphorylation.
Although there is some evidence that PKR dimerization is strongly dependent on dsRNA binding (19, 22) , many studies suggest that dimerization is relatively unaffected by point mutations in the DRBMs that impair dsRNA binding in vitro (14, (22) (23) (24) 30) . The results of the latter studies suggest that protein-protein interactions can mediate PKR dimerization in the absence of dsRNA binding. Wu and Kaufman (20) found that dimerization by isolated DRBMs could occur independently of dsRNA binding but that dimerization of full-length PKR with the isolated DRBM was dsRNA-dependent. To account for these findings, they proposed that dsRNA binding to full-length PKR was required primarily to dissociate the DRBMs from the kinase domain and unmask a dimerization surface in the DRBMs. However, recent evidence that only DRBM-II interacts with the kinase domain implies that DRBM-I is exposed and available for dimerization constitutively (17) . A second dimerization domain in PKR was localized to the 244 -296 interval, overlapping the N-terminal portion of the kinase domain (25) . Nanduri et al. (17) proposed that this region becomes available for dimerization after dissociation of DRBM-II from the kinase domain upon dsRNA binding and provides the critical dimerization surface in the enzyme. However, the importance of the 244 -296 interval for dimerization by full-length PKR has not been addressed experimentally.
An alternative model for PKR activation was proposed by Patel and Sen (31) in which dimerization occurs independently of dsRNA binding, and dsRNA (or alternative stimulatory ligands) activate a preformed PKR dimer by producing a conformational change in the protein. It was found that mutating residue Ala-67 to Glu in DRBM-I abolished dimerization of the N-terminal domain of PKR without affecting dsRNA binding. This suggested that Ala-67 is required for a critical proteinprotein contact between the dimerized DRBMs. The fact that A67E had a much greater effect on kinase function than did a mutation (K60A) that abolished dsRNA binding without impairing dimerization led these workers to propose that dimerization precedes dsRNA binding and that PKR dimers can be activated in yeast independently of dsRNA.
The solution structure of the N-terminal domain of PKR showed that DRBMs I and II have topologies highly similar to that of other DRBMs (32, 33) , separated by a flexible linker of about 20 residues (34). The crystal structure of a complex I and II between  amino acid residues 10 -78 and 101-168 , respectively, and the third basic domain between residues 232 and 261. The kinase domain spans residues 267-551 and contains the conserved subdomains labeled I-XI. A deletion mutant (⌬244 -296) lacking a predicted dimerization interface (25) is indicated below the schematic. B, amino acid alignment of Xlrbpa-2 with PKR DRBMs I and II. Three dsRNA contact regions in Xlrbpa-2 which interact independently with dsRNA (35) are indicated, with residues making side chain or backbone interactions with the RNA shown in boldface. Residues in PKR homologous to those in Xlrbpa-2 making side chain interactions with dsRNA were replaced by Ala in this study and are indicated by (a dot) as is the replacement of Ala-67 by Glu (A67E mutation). The locations of ␣-helices and ␤-sheets in the structure of the PKR DRBMs are indicated below the sequence (17, 34) . C, FLAG-tagged PKR alleles (FL-PKR) analyzed in this study. The alleles with mutations in the DRBMs are designated by the number of Ala substitutions in DRBM I or II, and the specific substitutions are indicated in parentheses. WT, wild-type. between dsRNA and a single DRBM from the Xenopus laevis RNA-binding protein A (Xlrbpa-2) revealed three different contact regions in the DRBM which interact with two successive minor grooves and the intervening major groove on one face of the dsRNA molecule (35) . The same three RNA contact regions were identified in the NMR structure of the DRBM-3 of Drosophila Staufen bound to an RNA stem-loop (36) . In view of these findings, we considered the possibility that certain PKR mutations studied previously which altered only one of three RNA contact regions in DRBM-I (e.g. K60A) might not completely impair dsRNA binding. In this event, conclusions about the dependence of dimerization and kinase activation on dsRNA binding based on such mutations would be questionable. In addition, the conclusion that dimerization by fulllength PKR is dsRNA-dependent derived from analysis of a single mutation (K64E) in DRBM-I (20) . With the finding that only DRBM-II interacts with the kinase domain (17), we wished to determine whether dsRNA binding by DRBM-II is required for dimerization.
Accordingly, we constructed point mutations designed to destroy side chain interactions in one, two, or all three predicted dsRNA contact regions in DRBMs I and II and examined their effects on dimerization by full-length PKR molecules expressed in yeast cells. Our results provide strong support for the idea that dimerization by full-length PKR is dependent on dsRNA binding, but they show that it occurs independently of the dimerization domain between residues 244 and 296. We also employed the DRBM point mutants to investigate whether dsRNA binding and dimerization stimulate autophosphorylation in the PKR activation loop. Using an antibody specific for phosphothreonine 451, we provide evidence that phosphorylation of this residue is stimulated by dsRNA binding. Finally, we show that Ser-33 and multiple autophosphorylation sites in the flexible linker between the DRBMs, and within kinase subdomain V, are largely dispensable for PKR function in yeast. Our data provide strong support for a model in which dsRNA binding enables dimer formation, enhancing autophosphorylation of Thr-451 in the activation loop with attendant activation of the eIF2␣ kinase function of PKR.
MATERIALS AND METHODS
Plasmids and Yeast Strains-Descriptions of the plasmids employed are given in Table I , and details of their construction will be provided upon request. 7 .0, 500 mM NaCl, 0.1% Triton X-100) supplemented with CPI and phosphatase inhibitor mixtures. Aliquots containing 500 g of protein were diluted to 100 l in IP buffer and incubated with anti-FLAG M2-agarose (Sigma) at 4°C overnight with rocking. The beads were collected by centrifugation, washed three times with IP buffer, resuspended in 30 l of 2 ϫ Laemmli sample buffer, and boiled for 5 min. The proteins were resolved by SDS-PAGE and subjected to immunoblot analysis as described above.
Analysis of PKR Expression and Activity in Mammalian Cells-HeLa cells grown in Dulbecco's modified Eagle's medium with 10% fetal bovine serum were treated with interferons (IFN) ␣/␤ and poly(I-C) as described in Fig. 6A . Cells were washed twice with cold phosphatebuffered saline containing CPI and phosphatase inhibitor mixtures described above and lysed in extraction buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100) containing CPI mixture and phosphatase inhibitors. For immunopurification of PKR, an aliquot of WCE containing 500 g of protein was incubated with PKR monoclonal antibody 71/10 (Ribogene/Questcor) for 2 h at 4°C with rocking. Immune complexes were collected with protein G-Sepharose beads (Amersham Pharmacia Biotech) and washed three times with extraction buffer plus CPI mixture and phosphatase inhibitors. Proteins were separated by SDS-PAGE, and immunodetection was conducted as described above.
In vitro kinase assays were carried out as described previously (6) except for details stipulated in the legends to Fig. 6 , B-D. PKR was purified as described previously (9) except that SP-Sepharose was used in place of S-Sepharose, and a heparin column replaced the hydroxylapatite and Mono S columns.
RESULTS

Mutations Destroying Predicted Amino Acid Side Chain-RNA Interactions in PKR DRBMs I and II Produce Additive
Reductions in Kinase Activity in Yeast-To investigate whether dimerization of PKR is dependent on dsRNA binding by one or both DRBMs, we made Ala substitutions predicted to destroy side chain interactions in all three regions that contact dsRNA in one or both DRBMs (Fig. 1, A-C) . These mutations were introduced into a FLAG epitope-tagged allele of PKR (FL-PKR) and expressed from a galactose-inducible promoter in a gcn2⌬ yeast strain (H1894). We also made the A67E substitution in DRBM-I reported to abolish dimerization (31) , and a deletion of residues 244 -296 containing the second dimerization domain in PKR (Fig. 1A ) (25) , to address the importance of these residues for dimerization by full-length PKR. The effects of the mutations on PKR function in vivo were determined by analyzing the growth rates of the resulting yeast transformants on different media (Table II , fourth through seventh columns).
When induced at high levels on galactose medium, wild-type PKR inhibits cell growth via a general inhibition of translation resulting from high level eIF2␣ phosphorylation. Thus, the strain bearing the FL-PKR allele, encoding FLAG-tagged wildtype PKR, failed to grow on galactose medium, whereas that expressing catalytically inactive FL-PKR-K296R grew well on this medium (Table II , fifth column). A low level of PKR expression under noninducing conditions (glucose medium) complements the failure of gcn2⌬ cells to grow on medium containing 3-aminotriazole (3-AT), an inhibitor of histidine biosynthesis. (Induction of GCN4 mRNA translation by eIF2␣ phosphorylation derepresses histidine biosynthetic enzymes and permits cell growth on 3-AT medium (37) .) Thus, the strain bearing FL-PKR grew on glucose medium containing 3-AT, whereas the FL-PKR-K296R transformant did not (Table II , sixth column). As expected, the transformants bearing FL-PKR-K296R or vector alone grew indistinguishably on both media (Table II) .
By comparing the growth of the various DRBM point mutants on these two media, and also on galactose medium containing 3-AT, we could infer their relative kinase activities in vivo (6) (Table II, fourth column; for details, see legend). The double Ala substitution of Ser-59 and Lys-60 in region 3 of DRBM-I (the FL-PKR-2AI allele) led to moderate reductions in kinase activity (Table II) , whereas Ala substitutions in the corresponding residues of DRBM-II (Thr-149 and Lys-150) in the FL-PKR-2AII allele had no discernible effect on kinase function. (The 2AI and 2AII allele names designate two Ala substitutions in DRBM-I or II, respectively.) A more substantial defect was observed when all four of these mutations were combined in PKR-2AIϩ2AII (Table II) , consistent with the previous conclusion that DRBMs I and II cooperate in binding dsRNA (42, 43) . Combining the Ala substitution of His-37 in region 2 of DRBM-I with the two mutations just described in region 3 of DRBM-I (producing FL-PKR-3AI) led to a greater reduction in kinase activity than was seen for the FL-PKR-2AI allele containing only region 3 mutations. This finding supports the idea that regions 2 and 3 make additive contributions to dsRNA binding by DRBM-I (35) . By contrast, the corresponding triple mutation in DRBM-II present in FL-PKR-3AII had no effect on kinase function, consistent with the previous conclusion that DRBM-I is more critically required than DRBM-II for dsRNA binding and kinase function (6, 42, 44) . The allele that combined all six of these mutations in both DRBMs (FL-PKR-3AIϩ3AII) was more defective than FL-PKR-3AI and had very low (but detectable) activity in these assays (Table II) .
Thus, DRBM-II becomes essential for PKR activity only when DRBM-I is severely impaired.
Combining two mutations in region 1 (N15A and T16A) and a third mutation in region 3 (K61A) with the aforementioned mutations in regions 2 and 3 of DRBM-I (yielding FL-PKR-6AI) reduced PKR function further than did the latter 3 mutations alone. Similarly, the FL-PKR-6AII allele containing the corresponding 6 substitutions in DRBM-II showed impaired kinase function, whereas the parental allele FL-PKR-3AII with only 3 mutations in DRBM-II had wild-type function. As expected, the FL-PKR-6AIϩ6AII allele containing all 12 mutations in both DRBMs I and II had very low activity. It was surprising, however, that it showed slightly greater activity than did FL-PKR-3AIϩ3AII bearing fewer mutations. This last observation could be explained by proposing that the 6AIϩ6AII mutations reduce the negative effect of the DRBMs on kinase activity (15, 20) , reducing the requirement for dsRNA binding and yielding higher kinase activity than that of FL-PKR-3AIϩ3AII. In agreement with previous results (31), the A67E mutation led to a substantial reduction in kinase activity, comparable to the effects of multiple substitutions in the contact points for dsRNA in DRBM-I (Table II) . The ⌬244 -296 mutation abolished kinase activity, as expected from the fact that it removes conserved residues in the kinase domain of PKR.
To eliminate the possibility that the reductions in kinase activity conferred by these mutations resulted from reductions in PKR expression, we conducted Western analysis on WCEs from the yeast strains described above following growth on galactose medium. In agreement with previous results, the mutant enzymes with reduced kinase activities were generally more abundant than those with higher activities ( Fig. 2A ). This phenomenon has been attributed to negative autoregulation of PKR expression which depends on its eIF2␣ kinase activity (6) . Thus, the 2AI product was expressed at higher levels than the 2AII product, the 3AI product was more abundant than the 3AII product, and the 6AII product was more highly expressed than the 3AII product. Furthermore, the 2AIϩ2AII product was expressed at higher levels than either the 2AI or 2AII product. These measurements of protein expression for the different mutant alleles shown in Fig. 2 are consistent with our assignments of their in vivo kinase activities based on cell growth assays (Table II , fourth column). However, the inverse relationship between kinase activity and protein expression did not strictly apply to the most heavily mutated FL-PKR alleles containing 6 or 12 substitutions in the DRBMs. Thus, although the 6AI, 6AIϩ6AII, and 3AIϩ3AII products were expressed at much higher levels than wild-type FL-PKR, they accumulated to lower levels than the relatively more active 3AI product ( Fig.  2A) . In the case of the 6AIϩ6AII product, this discrepancy may arise from the intrinsic instability of the protein resulting from 12 Ala substitutions (see below).
We also measured the levels of wild-type and mutant FL-PKR proteins by Western analysis in a different yeast strain (J82) containing an Ala substitution for Ser-51 in eIF2␣, the Fig. 1 . The second column lists the relative abilities of mutant and wild-type (WT) proteins in WCEs to bind poly(I-C)-agarose, based on the results in Fig. 3 . The Western signals in Fig. 3 were quantified and used to calculate the proportions of FL-PKR proteins in the input extracts that were recovered in the poly(I-C)-bound fractions and then expressed relative to the corresponding value for wild-type FL-PKR, which was set to 100. The results obtained from three or four independent experiments were averaged. The third column lists the relative dimerization activities of the FL-PKR proteins as determined by the coimmunoprecipitation assays shown in Fig. 4 . The Western signals in Fig. 4 were quantified and used to calculate the proportions of HA 3 -PKR in the input extracts which coimmunoprecipitated with each FL-PKR mutant protein. Each of these proportions was corrected for the immunoprecipitation efficiency of the FLAG-tagged mutant protein itself, and the resulting normalized values, averaged from three or four independent experiments, were taken as a measure of the dimerization activities of the mutant proteins. Relative dimerization activity from strongest to weakest was scored as: ϩϩ, ϩ, ϩ/Ϫ, Ϫ/ϩ, and Ϫ. The fourth column lists the relative in vivo kinase activities of the FL-PKR alleles based on the results of growth assays summarized in the fifth through seventh columns. Plasmids carrying the indicated PKR alleles were introduced into the gcn2⌬ yeast strain H1894 expressing wild-type eIF2␣. Patches of transformants were grown to confluence on glucose containing (Glc) medium and replica plated to Glc medium plus 30 mM 3-AT (Glc 3-AT), to medium containing 2% raffinose and 10% galactose (SGal), and to SGal plus 30 mM 3-AT (Gal 3-AT). Plates were incubated for 4 -6 days at 30°C and growth was scored each day relative to that of the wild-type FL-PKR transformants. The growth phenotypes on the three media were used to assign relative kinase activities as follows. The four alleles giving growth on SGal equivalent to that of vector alone (scored as ϩϩ) were assigned the lowest kinase activities, from 0 to 2, ranked according to their growth on Gal 3-AT, with greater growth corresponding to higher activity. The three alleles scored as ϩ on SGal were assigned kinase activities from 3 to 5, according to their growth on Gal 3-AT. The alleles scored as ϩ/Ϫ and Ϫ/ϩ on SGal were assigned activities of 6 and 7, respectively. The alleles scored as Ϫ on SGal were assigned the highest activities, either 8 or 11. Because these last alleles are lethal on galactose medium, their Gal 3-AT phenotype is irrelevant. The two alleles in this class which grew like wild-type on Glc 3-AT were assigned activities of 11. The 2AI construct was assigned an activity of 8 because it showed no growth on Glc 3-AT, and previously described PKR alleles (6) had growth rates on Glc 3-AT of ϩ/Ϫ or ϩ, corresponding to kinase activities of 9 and 10, respectively. The last column contains the expression levels of the mutant FL-PKR proteins relative to wild-type FL-PKR (assigned a value of 1.0) as determined by Western blot analysis of 30 g of WCEs from transformants of gcn2⌬ strain J82 grown on galactose medium. The blot was probed with PKR polyclonal antibodies (K-17), developed with the ECL system, and the results of two independent blots were quantified by densitometry and averaged. 
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site of phosphorylation by PKR and GCN2. In agreement with previous results (6), FL-PKR-K296 and FL-PKR were expressed at similar levels during growth on galactose medium because of loss of autoregulation of PKR expression in this strain. All of the other mutant FLAG-tagged PKR proteins were expressed at comparable levels, except for the 6AIϩ6AII product that accumulated to only ϳ30% of the level of wild-type FL-PKR (data summarized in Table II , last column). Finally, we analyzed the level of eIF2␣ phosphorylation on Ser-51 for selected FL-PKR mutants in another strain that is also defective for PKR autoregulation. This strain (GP3299) contains wild-type eIF2␣ but harbors a mutation in the GCD2-encoded subunit of eIF2B which eliminates the inhibitory effect of eIF2␣ phosphorylation on translation. Because the levels of wild-type and mutant PKR proteins are similar in this strain, the amounts of eIF2␣ phosphorylation observed in these transformants should be roughly proportional to the specific activities of the PKR proteins being expressed. To measure the relative levels of eIF2␣ phosphorylated on Ser-51, we carried out Western analysis of whole cell extracts using antibodies specific for phosphorylated Ser-51 (pS51) and also with polyclonal eIF2␣ antibodies. The ratios of Western signals from these two blots were calculated and normalized for the amount of PKR in the extract. As expected, the wild-type FL-PKR transformant had readily detectable amounts of pS51, whereas none was observed in the strain containing catalytically inactive FL-PKR-K296R (Fig. 2B, lanes 1-4) . The strains containing the 3AIϩ3AII and 6AIϩ6AII mutant alleles had normalized ratios of pS51 to total eIF2␣ that were ϳ60% of that observed for wild-type FL-PKR, indicating a defect in eIF2␣ kinase activity in these mutants. The FL-PKR-2AIϩ2AII transformant showed a smaller defect, consistent with the results of growth tests shown in Table II . These reductions in pS51 levels may seem modest in relation to the substantial increases in cell growth and PKR expression associated with these DRBM mutations; however, small increases in the proportion of total eIF2␣ that is phosphorylated on Ser-51 can have a large impact on the rate of translation in vivo (37) . It also should be noted that the 3AIϩ3AII and 6AIϩ6AII alleles induced GCN4 expression on galactose medium (Table II , Gal 3-AT), consistent with the residual eIF2␣ phosphorylation present in the transformants (Fig. 2B) .
PKR Dimerization in Vivo Is Strongly Correlated with dsRNA Binding Activity-We verified that the mutations made in the DRBMs reduce dsRNA binding by comparing mutant and wild-type FL-PKR proteins in cell extracts for binding to poly(I-C)-agarose beads. To ensure that similar amounts of mutant and wild-type proteins were being compared, we used extracts from the J82 transformants described above in which PKR autoregulation was abolished. The bound proteins were eluted from the poly(I-C)-agarose beads and resolved by SDS-PAGE along with aliquots of the input extracts (Fig. 3) . The results of replicate binding assays were quantified and are summarized in Table II (second column) .
As expected, the wild-type FL-PKR product bound to poly(I-C)-agarose, whereas the PKR-⌬14 -257 product, lacking (dark) ) is a darker exposure of the top panel. B, the indicated FL-PKR alleles were introduced into gcn2⌬ strain GP3299 and cultured on galactose medium. 10 (1X) or 20 g (2X) of WCEs was subjected to immunoblot analysis using antibodies that recognize eIF2␣ phosphorylated on Ser-51 (pS51). The blot was stripped and reprobed with eIF2␣ antibodies (middle panel) and PKR antibodies (K-17) (bottom panel). The specific eIF2␣ kinase activity for each protein was estimated by calculating the ratio of pS51 to eIF2␣ Western signals and normalizing it for the PKR signal. The normalized ratios are plotted graphically at the bottom relative to the value for wild-type PKR, set to 100%.
FIG. 3.
Mutation of multiple residues predicted to contact dsRNA in the DRBMs of PKR is required to impair dsRNA binding activity in vitro. Transformants of SUI2-S51A strain J82 containing the indicated FL-PKR alleles (except for PKR-⌬14 -257, which is untagged) were cultured on galactose medium, and 200 g of WCEs was incubated with poly(I-C)-agarose. Proteins bound to the resin were eluted by boiling in sample buffer and subjected to immunoblot analysis using PKR antibodies (K-17). Lanes labeled input contained 25% of the starting extracts.
DRBMs I and II, showed no binding activity in this assay (Fig.  3, lanes 2 and 3) . Surprisingly, the catalytically inactive protein FL-PKR-K296R showed higher levels of dsRNA binding than did wild-type FL-PKR. Somewhat elevated levels of dsRNA binding also were observed for the catalytically inactive ⌬244 -296 product and for the 2AII and 3AII products. At present, we do not understand the basis for the elevated levels of dsRNA binding observed for these mutants. Most of the remaining mutants showed reductions in poly(I-C) binding which correlated well with the extent of kinase impairment. Thus, the 2AI and 2AII products showed high level dsRNA binding, whereas the combination of these mutations in the 2AIϩ2AII construct produced low levels of dsRNA binding (Fig. 3, lanes 4 -6; Table  II ). The 3AI product showed less dsRNA binding than did the 2AI product, and the 3AIϩ3AII protein had lower binding activity than did the 3AI product. (The amount of 3AI product that bound to poly(I-C) in the particular assay shown in Fig. 3 was considerably lower than that observed in several replicate assays not shown (for details, see Table II ).) As expected, the 6AII product had reduced dsRNA binding activity compared with wild-type but showed less binding activity than did the 6AI product (Table II and Fig. 3 ). It is noteworthy that the A67E mutation in DRBM-I completely abolished poly(I-C) binding by FL-PKR, at odds with a previous report indicating that this mutation had little impact on dsRNA binding in vitro (31) .
We next examined the ability of the mutant FL-PKR proteins to form heterodimers with a wild-type PKR protein tagged with three copies of the HA epitope (HA 3 -PKR) that was coexpressed from the galactose-inducible promoter in the same yeast transformants. The FL-PKR proteins were purified from cell extracts using immobilized FLAG antibodies and probed with HA antibodies for the presence of copurifying HA 3 -PKR. As shown in Fig. 4 , a large proportion of the HA 3 -PKR was coimmunoprecipitated with wild-type FL-PKR, whereas none was recovered from an extract containing untagged PKR (compare lanes  3 and 6) . Thus, the presence of HA 3 -PKR in the immunopurified fraction was dependent on the presence of FL-PKR. The amount of HA 3 -PKR that coimmunoprecipitated with each FL-PKR mutant was measured and corrected for the immunoprecipitation efficiency of the FLAG-tagged mutant protein itself (Fig. 4) . These normalized amounts of coimmunoprecipitating HA 3 -PKR were taken as a measure of the relative dimerization activities of the mutant proteins. The results obtained from the assays shown in Fig. 4 (and replicate experiments not shown) are summarized qualitatively in Table II (third column; for details, see legend).
All of the FL-PKR mutants with Ͼ50% of wild-type dsRNA binding activity were indistinguishable from wild-type FL-PKR in the ability to form heterodimers with HA 3 -PKR in vivo. This category included the ⌬244 -296, 2AI, 2AII, 3AII, and 6AII products (Table II , second and third columns). The remaining mutants with more serious defects in dsRNA binding displayed reduced ability to heterodimerize with HA 3 -PKR. Thus, the 3AI and 2AIϩ2AII products had moderate and low level dimerization activities, respectively, whereas the 3AIϩ3AII, 6AI, and 6AIϩ6AII products formed only trace amounts of heterodimers with HA 3 -PKR. Considering the good correlation we observed between dsRNA binding and heterodimer formation, we conclude that formation of stable PKR dimers in yeast depends strongly on dsRNA binding. In keeping with its failure to bind dsRNA (Fig. 3) , the A67E product was nearly incapable of dimerizing with HA 3 -PKR (Fig. 4) .
dsRNA Binding by PKR Is Required for High Level Autophosphorylation of Thr-451 in the Kinase Activation Loop-
Previously, we presented strong genetic evidence that autophosphorylation of PKR on Thr-451 is required for kinase activity in vitro and in yeast cells; however, we could not detect phosphorylated Thr-451 (pT451) by mass spectrometry sequencing of phosphopeptides from PKR purified from yeast (11) . Here we obtained physical evidence for Thr-451 phosphorylation by Western analysis of PKR expressed in yeast using antibodies specific for pT451. As shown in Fig. 5A (upper panel) , the pT451 antibody reacted with wild-type PKR and with PKR-S242A, T255A, T258A containing Ala substitutions in three other autophosphorylation sites (10). However, it did not react with catalytically inactive PKR-K296R, nor with PKR-T451A and PKR-T446A. All five proteins were readily detected on the same blot using polyclonal antibodies against PKR (Fig.  5A, lower panel) . We verified that detection of wild-type PKR by Western analysis with the pT451 antibodies was abolished by the addition of a phosphorylated peptide containing pT451, but not by the unphosphorylated version of the same peptide (data not shown). The fact that T446A eliminated the reactivity of PKR with pT451 antibodies suggests that autophosphorylation of Thr-446 is a prerequisite for phosphorylation of Thr-451. It could be argued that T446A does not prevent phosphorylation of Thr-451 but instead abolishes recognition of pT451 by FIG. 4 . PKR dimerization in vivo is functionally dependent on dsRNA binding activity. A transformant of SUI2-S51A strain J82 expressing HA 3 -PKR from plasmid p2984 was transformed with plasmids containing the indicated FL-PKR alleles or untagged wildtype (WT) PKR. Transformants were cultured on galactose, and 100 g of WCEs was incubated with anti-FLAG M2 agarose. Proteins bound to the resin were eluted by boiling in sample buffer and subjected to immunoblot analysis using anti-HA and anti-FLAG antibodies. Lanes labeled I (input) contained 100 g of the starting extracts, the S (supernatant) lanes contained 10% of the unbound fractions, and the P (precipitated) lanes contained the entire bound fractions. the phosphospecific antibody. This seems unlikely because the pT451 antibody was raised against a synthetic phosphopeptide that does not include Thr-446.
To corroborate these findings, we sought to demonstrate that reactivity of wild-type PKR with pT451 antibodies was eliminated by treatment of the extract with a protein phosphatase. As shown in Fig. 5B , wild-type PKR in untreated extracts had a lower electrophoretic mobility than did PKR-K296R (PKR panel, lanes 1 and 4) , which is attributable to extensive autophosphorylation of the wild-type enzyme (10) . Treatment of extracts with CIP increased the mobility of wild-type PKR to nearly that of PKR-K296R, whereas inclusion of phosphatase inhibitors reversed the effect of CIP on PKR mobility. As expected, treatment with CIP in the presence or absence of inhibitors had no effect on the mobility of the defective kinase (Fig. 5B, PKR panel) . Thus, it appears that CIP treatment removed the majority of phosphorylated residues from wildtype PKR. Importantly, CIP treatment also greatly decreased the reactivity of wild-type PKR to pT451 antibodies, in a manner reversed by phosphatase inhibitors (Fig. 5B, pT451 panel,  lanes 1-3) . We conclude that the pT451 antibodies specifically recognize PKR autophosphorylated on Thr-451.
We next investigated whether autophosphorylation of Thr-451 is stimulated by dsRNA binding. In the first approach, the pT451 antibodies were employed in Western analysis of yeast extracts containing FL-PKR proteins bearing the multiple mutations in both DRBMs which eliminated dsRNA binding and dimerization. The products of the 2AIϩ2AII, 3AIϩ3AII, and 6AIϩ6AII mutant alleles contained pT451 at levels only ϳ25% of that observed for wild-type FL-PKR (Fig. 5C, lanes 1-10) . The 6AI allele also showed a clear reduction in the amount of pT451 compared with that present in wild-type (Fig. 5C, lanes  11-13) ; however, we could not detect a significant reduction in pT451 content for any other mutant proteins bearing fewer substitutions in the DRBMs (data not shown). These findings are consistent with the idea that autophosphorylation of Thr-451 is stimulated by dsRNA binding and dimerization of PKR. Below, we discuss the possible origin of the residual pT451 observed for the heavily mutated proteins that cannot bind dsRNA.
To obtain independent evidence that Thr-451 autophosphorylation is stimulated by dsRNA binding, we sought to demonstrate that phosphorylation of Thr-451 by wild-type PKR could be stimulated by dsRNA. PKR isolated from yeast cells is highly active and cannot be stimulated further by treatment with dsRNA (6) . Hence, we immunopurified PKR from cultured human (HeLa) cells that were treated with IFN-␣ and ␤ (IFN␣/␤) to induce PKR and also with poly(I-C) to activate the enzyme prior to purification. Western blot analysis of the resulting extracts confirmed that PKR expression was induced by IFN␣/␤ and that phosphorylation of eIF2␣ on Ser-51 was stimulated by poly(I-C) treatment of the cells (Fig. 6A) . PKR was immunopurified, and the immune complexes were incubated with [
32 P]ATP and analyzed by SDS-PAGE and autoradiography. As expected, PKR from the cells treated with both IFN␣/␤ and poly(I-C) had higher autokinase activity than did the enzyme immunopurified from cells treated with IFN␣/␤ alone (Fig. 6B) . In a separate experiment, the immune complexes were incubated with nonradioactive ATP and subjected to Western blot analysis with antibodies against PKR pT451. The results showed that only the activated form of PKR isolated from poly(I-C)-treated cells reacted strongly with the pT451 antibodies, and this occurred only when PKR was incubated in the presence of ATP (Fig. 6C, lane 6) . Thus, reactivity with pT451 antibodies was correlated with high level autokinase activity of the immunopurified enzyme. To explain the fact that pT451 was detected in this last experiment only after incubation of the in vivo activated enzyme with ATP, we suggest that pT451 was dephosphorylated either prior to or during isolation of the enzyme from the poly(I-C)-treated cells and was regenerated in vitro on addition of ATP.
Finally, we wished to demonstrate that phosphorylation of Thr-451 could be stimulated by dsRNA treatment of purified PKR. Toward this end, PKR isolated from 293 cells was immunoprecipitated, incubated with ATP in the presence or absence of poly(I-C), and probed by Western analysis using pT451 antibodies. As shown in Fig. 6D , we detected pT451 only when the PKR was incubated with poly(I-C), supporting the idea that Thr-451 autophosphorylation is stimulated by dsRNA. Unexpectedly, we found that immunoprecipitation of the PKR was a prerequisite for poly(I-C)-dependent Thr-451 phosphorylation in these last experiments (data not shown). Several ways to account for the stimulatory effect of immunoprecipitation on Thr-451 phosphorylation are considered below.
Mutations in Other Autophosphorylation Sites Located between the DRBMs or within the Kinase Domain Insert Have
Little Impact on PKR Function in Yeast-Previously, mass spectrometric analysis of PKR expressed in yeast identified phosphorylation sites at Ser-33 in DRBM-I, a cluster of six sites in the linker region between the DRBMs (residues 81-107) and a cluster of six sites in the 315-356 interval located in a large insert between kinase subdomains IV and V (12) . There are 8 Ser and Thr residues in the 315-356 interval, and only six autophosphorylation sites were detected by mass spectrometry; hence 2 of the Ser or Thr residues in this interval may not be autophosphorylated. Similarly, there are 7 Ser and Thr residues in the 81-107 interval, and only six autophosphorylation sites were detected by mass spectrometry. Direct chemical sequencing of phosphopeptides derived from PKR purified from mammalian cells and autophosphorylated in vitro confirmed the presence of multiple autophosphorylation sites between DRBMs I and II, identifying Ser-83, Thr-88, Thr-89, and Thr-90 as specific phosphorylated residues in this interval (13) .
To address the importance of these additional phosphorylation sites, we made a single Ala substitution at Ser-33 (S33A) and 7 simultaneous Ala substitutions at all of the potential sites located between DRBMs I and II (7Ala). Additionally, 10 simultaneous Ala substitutions were made to remove all eight potential phosphorylation sites in the kinase domain insert plus residues Ser-357 and Ser-359 located immediately upstream (10Ala). The 17Ala allele combines all of the mutations present in the 10Ala and 7Ala alleles. The mutant proteins were expressed in the gcn2⌬ yeast strain H1894 and compared with wild-type PKR for their effects on cell growth and resistance to 3-AT, as described above. Surprisingly, the S33A, 7Ala, 10Ala, and 17Ala mutations had no detectable effect on PKR function (Fig. 7A) . Consistently, combining the 17Ala substitutions with the S242A, T255A, T258A mutations (3Ala) (producing the 20Ala allele), did not reduce kinase activity any further than the 3Ala substitutions alone (Fig. 7A) .
In accordance with our results on the 7Ala allele, Taylor et al. (13) reported recently that Ala substitutions in residues Ser-83, Ser-88, Ser-89, and Thr-90 had no effect on PKR func- FIG. 6 . Poly(I-C) stimulates Thr-451 phosphorylation and PKR kinase activity in HeLa cells. A, HeLa cells were treated with 1,000 units/ml IFN␣/␤ for 18 h, with 1,000 units/ml IFN-␣/␤ for 18 h and then with 100 g/ml poly(I-C) for an additional 6 h, or were untreated. WCEs were prepared, and 10 g (1X) or 20 g (2X) of total protein was subjected to immunoblot analysis with antibodies against pS51 in eIF2␣ (middle panel). The blot was stripped and reprobed with antibodies against total human eIF2␣ (bottom panel) or PKR (N-18) (top panel). B, WCEs were prepared from HeLa cells treated as in A, and PKR was immunoprecipitated with monoclonal antibody 71/10. Immune complexes were incubated in kinase reaction buffer in the presence of 10 Ci of [␥-
32 P]ATP (6,000 Ci/mmol) for 30 min at 30°C. The reaction was terminated by the addition of 6 ϫ SDS sample buffer, boiled for 10 min, resolved by SDS-PAGE, and visualized by autoradiography. C, PKR was immunopurified from HeLa cell extracts as in B, and immune complexes were incubated in kinase reaction buffer with or without nonradioactive 40 M ATP. Samples were subjected to immunoblot analysis using antibodies against pT451 or PKR (N-18). The arrow points to a band with the expected mobility of PKR. D, purified PKR was incubated with 40 M ATP in the presence or absence of 150 ng/ml poly(I-C) in kinase reaction buffer at 30°C for 30 min and immunoprecipitated with PKR monoclonal antibodies (71/10). The immunocomplexes were incubated again with 40 M ATP in the presence or absence of 150 ng/ml poly(I-C) in kinase reaction buffer and subjected to immunoblot analysis using antibodies against pT451 or PKR (N-18).
FIG. 7.
Inferred in vivo kinase activities of PKR alleles bearing mutations in multiple autophosphorylation sites. A, the schematic at the bottom depicts the PKR primary structure, as in Fig. 1A , with the locations of mutations in the PKR-7Ala, PKR-3Ala, PKR10Ala, PKR-T446A, and PKR-T451A alleles indicated beneath. The relative in vivo kinase activities of the indicated PKR alleles were determined as described in Table II . B, selected transformants of strain H1894 containing the indicated PKR constructs were streaked on synthetic complete galactose medium and incubated for 5 days at 30°C. tion in yeast. The results we obtained for the 10Ala mutation were unexpected, however, in light of a previous report that the single S355A substitution destroyed PKR function in yeast using the same growth assays employed here (45) . We constructed the PKR-S355A allele and found that it too was indistinguishable from wild-type PKR in our growth assays (data not shown). We have no explanation for the discrepancy between our results and those published previously.
We analyzed the mutations in multiple phosphorylation sites using a more stringent test for PKR function by combining them with the T446A substitution in the activation loop of the kinase domain. The latter mutation substantially impairs, but does not abolish, PKR activity in the growth assays. As shown previously, the 3Ala substitution exacerbated the phenotype of T446A (11) (Fig. 7A) , as did the 10Ala and 17Ala substitutions, leading to enhanced growth on galactose medium compared with that seen for the PKR-T446A single mutant (Fig. 7, A and  B) . Thus, autophosphorylation of one or more sites located between kinase subdomains IV and V may be important for kinase activity when autophosphorylation in the activation loop is eliminated. In contrast, the S33A and 7Ala substitutions had little or no effect on cell growth when combined with T446A (Fig. 7, A and B) . Moreover, the 10Ala mutation was indistinguishable from the 17Ala mutation in exacerbating the phenotype of T446A, consistent with the idea that autophosphorylation of sites between DRBMs I and II (inactivated by 7Ala) makes little or no contribution to PKR activity in yeast.
To provide biochemical evidence that these additional phosphorylation sites are utilized in yeast, we examined the electrophoretic mobilities of the mutant proteins by Western analysis. In the first experiment shown in Fig. 8A , the extracts were treated with CIP in the presence and absence of phosphatase inhibitors prior to SDS-PAGE. In the presence of CIP inhibitors, the mobilities of the PKR proteins containing 7Ala, 10Ala, 17Ala, or 20Ala substitutions were greater than that of wildtype PKR and more similar to that of catalytically inactive PKR-K296R, as would be expected if these mutations remove autophosphorylation sites (Fig. 8A, ϩ lanes) . The 7Ala mutations led to a greater increase in mobility than did the 10Ala substitutions (lanes 2, 4, and 6) , suggesting that sites located between the DRBMs are phosphorylated more extensively than those between kinase subdomains IV and V (13) . Consistently, treatment with CIP in the absence of inhibitors led to smaller increases in mobility for the 7Ala, 17Ala, and 20Ala mutants than for the 10Ala and wild-type enzymes (Fig. 8A, compare ϩ and Ϫ lanes). However, even PKR-20Ala migrated more slowly than did PKR-K296R in the presence of CIP inhibitors ( lanes  19 and 21) , and the mobility of PKR-20Ala, but not that of PKR-K296R, was increased by CIP treatment in the absence of inhibitors (lanes 19 -22) . These last findings imply the presence of additional phosphorylated residues in the 20Ala protein (at a minimum, pS33, pT446, and pT451), in keeping with its relatively high kinase activity in vivo (Fig. 7A) .
Combining the T446A substitution with the 20Ala mutations increased the mobility of the mutant PKR protein to the point where it was indistinguishable from catalytically inactive PKR-K296R (Fig. 8B) , suggesting the absence of nearly all phosphorylation sites in PKR-T446A,20Ala. Given that T446A abolishes phosphorylation of Thr-451 (Fig. 5A) , Ser-33 is the only known phosphorylation site remaining in this mutant protein.
As shown in Fig. 7A , PKR-T446A,20Ala has readily detectable kinase activity in vivo, but Ser-33 makes no detectable contribution to kinase function. Thus, either autophosphorylation is not essential for PKR activity, or additional autophosphorylation sites remain to be identified which are required for the residual kinase function of PKR-T446A,20Ala.
We showed previously that Ala replacement of Thr-451 in the activation loop abolishes the autokinase and eIF2␣ kinase activities of PKR in vitro and in yeast cells (11) . If autophosphorylation of Thr-451 is stimulated by dsRNA binding and dimerization, as concluded above, then mutations in the DRBMs which diminish Thr-451 phosphorylation should reduce bulk autophosphorylation by PKR. As shown in Fig. 8C , the 2AIϩ2AII, 3AIϩ3AII, and 6AIϩ6AII mutants all migrated more rapidly than did wild-type PKR, and more similarly to PKR-K296R, as expected if the DRBM mutations reduce autophosphorylation of many sites in PKR. Consistently, treatment with CIP in the absence of inhibitors led to smaller increases in mobility for the three DRBM mutants (particularly 6AIϩ6AII) than it did for the wild-type enzyme (Fig. 8D , compare ϩ and Ϫ lanes for each protein). These findings confirm that dsRNA binding and dimerization are required for autophosphorylation by PKR on many sites in addition to Thr-451. end, we introduced Ala substitutions at all three predicted regions of contact with dsRNA in DRBMs I and II and analyzed their effects on dsRNA binding and dimerization by PKR proteins expressed in yeast. A nearly complete loss of dsRNA binding in our in vitro assays required alanine substitutions made simultaneously in contact region 3 of both DRBMs (FL-PKR-2AIϩ2AII) or simultaneous alterations in all three contact regions of DRBM-I (FL-PKR-6AI). Importantly, we observed a dramatic defect in dimerization only for these and more extensively mutated constructs (FL-PKR-3AIϩ3AII and FL-PKR-6AIϩ6AII) which completely lacked dsRNA binding activity in vitro. Additionally, the construct with alterations in contact regions 2 and 3 of DRBM-I (FL-PKR-3AI) showed partial reductions in both dsRNA binding and dimerization. Thus, we observed a strong correlation between the ability of PKR molecules to bind dsRNA in vitro and to dimerize in vivo.
Our mutations were designed to disrupt side chain interactions between the DRBM and dsRNA without affecting the overall topology of the DRBM. Indeed, contact regions 2 and 3 of Xlrbpa-2 reside in loops located between ␤ strands 1 and 2, or ␤3 and ␣-helix 2, respectively (35) . Hence, the 3AI and 3AII mutations should impair dsRNA binding without disrupting the structures of the DRBMs. Accordingly, the fact that PKR-3AIϩ3AII cannot dimerize is a strong indication that formation of stable PKR dimers is critically dependent on binding to dsRNA. This conclusion is at odds with several previous reports indicating that dimerization can occur independently of dsRNA binding (14, (22) (23) (24) 30) . At least in some of these cases, single substitutions made in DRBM-I probably did not completely eliminate dsRNA binding. To avoid this complication, we progressively removed predicted dsRNA contacts in both DRBMs I and II. In accordance with our results, Wu and Kaufman (20) showed that the K64E mutation in DRBM-I impaired the ability of full-length PKR-K296P to dimerize with an N-terminal fragment containing wild-type DRBMs (the BD fragment). Our study extends their findings in providing evidence that stable dimer formation by two full-length functional PKR molecules is dependent on dsRNA binding by both subunits of the dimer.
Because introducing the K64E mutation into the BD fragment did not impair its ability to dimerize with the wild-type BD segment, Wu and Kaufman proposed that the isolated DRBMs can dimerize independently of dsRNA through proteinprotein contacts (14) . To account for their subsequent finding that dsRNA binding was required for dimerization of fulllength PKR with the BD segment, they suggested that dsRNA binding was required primarily to dissociate the DRBMs from the kinase domain and unmask a dimerization surface in the DRBMs (20) . Having found that only DRBM-II binds tightly to the kinase domain, Nanduri et al. (17) proposed that dsRNA binding to DRBM-I is required for dimerization because it stimulates cooperative dsRNA binding to DRBM-II, dissociating the latter from the kinase domain and unmasking the 244 -296 dimerization surface in the kinase domain. Our finding that residues 244 -296 are dispensable for dimerization refutes the idea that this segment is the essential dimerization surface in PKR. If dsRNA stimulates dimerization by eliminating interaction of DRBM-II with the kinase domain, then destroying dsRNA binding by DRBM-II might be expected to impair dimerization. Inconsistent with this prediction, the six Ala substitutions in DRBM-II in the 6AII allele produced no reduction in PKR dimerization (Table II and Fig. 4) . To maintain this aspect of the model proposed by Nanduri et al., it seems necessary to propose that binding of dsRNA to DRBM-I can indirectly disrupt interaction of DRBM-II with the kinase domain in the absence of dsRNA contacts in DRBM-II.
In contrast to the models of Wu and Kaufman (20) and Nanduri et al. (17) , it was proposed by Patel and Sen (31) that PKR can dimerize in the absence of dsRNA and that preformed PKR dimers can be activated either by dsRNA or other ligands. This idea was based on their finding that the A67E mutation in DRBM-I destroyed dimerization with little effect on dsRNA binding and that A67E impaired kinase activity much more than did the K60A mutation, which impaired dsRNA binding but not dimerization. These findings implied that protein-protein contact between DRBMs dependent on Ala-67 was more important than dsRNA binding for PKR dimerization. In our assays, however, A67E abolished dsRNA binding. Hence, the failure of FL-PKR-A67E to dimerize may result from impaired dsRNA binding rather than loss of a critical protein-protein contact. Given its location in ␣-helix 2 of DRBM-I, and the strong conservation of this residue (34), the A67E mutation probably disrupts the secondary or tertiary structure of DRBM-I. The fact that dimerization and kinase function were not strongly impaired by the K60A mutation (31) can be explained by proposing that this single substitution in DRBM-I is not severe enough to destroy dsRNA binding by full-length PKR in vivo.
Although our results provide strong support for the idea that dsRNA binding is required to form stable PKR dimers in vivo, the number and relative importance of the molecular interactions that stabilize PKR dimers remain unclear. We favor the idea that binding of two PKR molecules to the same molecule of dsRNA contributes substantially to the stability of a PKR dimer. Protein-protein interactions are also likely to be important, including the proven association involving residues 244 -296 (25) . Because this last interaction is dispensable for dimerization by full-length PKR, interactions between the DRBMs, or additional interactions between the two kinase domains in the PKR dimer, also are predicted. Indeed, we recently observed dimerization by isolated PKR DRBMs purified under conditions that exclude dsRNA contamination. 2 Although none of these interactions alone may be sufficient to support stable dimer formation under physiological conditions, in aggregate they could produce a stable ternary complex consisting of two PKR molecules bound to the same molecule of dsRNA (Fig. 9) . We reached the same conclusion previously for the composition of a stable heterodimer between PKR and the DRBM-containing protein E3, wherein both proteins are bound to the same molecule of dsRNA (46) .
It was surprising that the 2AI mutation in dsRNA contact region 3 of DRBM-I (S59A,K60A) did not impair dsRNA binding in our assays. This finding is at odds with previous results indicating that PKR-K60A completely lacked dsRNA binding activity (31) . Likewise, we reported previously that a cluster of mutations in residues 58 -60 reduced dsRNA binding activity to Ͻ5% of wild-type, although it impaired PKR activity in yeast by the same moderate amount observed here for the 2AI mutation (6, 42) (Table II) . The fact that the 2AI mutation significantly reduced PKR function in yeast (Table II) makes us suspect that it produces a small reduction in dsRNA binding in vivo which our poly(I-C) binding assays were not sensitive enough to detect. One difference between our binding assays and those described previously is that we employed full-length PKR proteins made in yeast rather than in rabbit reticulocyte lysates. Perhaps PKR is associated with different proteins or contains different post-translational modifications which affect dsRNA binding when synthesized in these two systems. Because our assays for dsRNA binding, dimerization, and kinase activity all used the same source of PKR proteins expressed in yeast, they should allow a direct comparison of the effects of DRBM mutations on these different activities of PKR.
It was also unexpected that the A67E mutant had greater kinase activity than did the 3Aϩ3AII mutant, even though both displayed the same severe defects in dsRNA binding and dimerization. Perhaps A67E perturbs the structure of DRBM-I in a way that indirectly impairs the postulated inhibitory interaction of DRBM-II with the kinase domain (17, 20) , permitting substantial kinase activity in the absence of dsRNA binding or dimerization.
Autophosphorylation of Thr-451 Is Dependent on Thr-446 and Stimulated by dsRNA Binding-Autophosphorylation in the activation loop of PKR is critical for PKR function (11) , and a second goal of this study was to provide evidence that dsRNA binding and dimerization stimulate autophosphorylation of the activation loop. Using an antibody specific for pT451, we obtained the first physical evidence for autophosphorylation of this important residue. Unexpectedly, pT451 was eliminated from PKR expressed in yeast by the T446A mutation, suggesting that autophosphorylation of Thr-446 is a prerequisite for pT451. This last conclusion seems at odds with the fact that PKR-T446A has detectable kinase activity whereas PKR-T451A is inactive (11) . Presumably, part of the defect associated with T451A derives from structural perturbation of the activation loop, unrelated to the function of Thr-451 as a phosphorylation site. In this view, T446A prevents autophosphorylation at both 446 and 451, and the T446A phenotype reveals the true impairment of PKR function associated with a failure to autophosphorylate the activation loop.
The phosphorylation of Thr-197 in the activation loop of protein kinase A is extremely stable and considered to be a step in protein maturation rather than a regulatory event (47, 48) . In contrast, phosphorylation of Thr-183 and Thr-185 in the activation loop of mitogen-activated protein kinase ERK2 by MEK2 (49) is highly regulated and represents a key event in the activation of ERK2 by mitogenic agents (50) . Given the critical importance of Thr-451 for PKR activity, if autophosphorylation of this residue is dependent on dsRNA binding, it would represent an important molecular marker of PKR activation. We found that the amount of pT451 in PKR expressed in yeast was reduced to about 25% of the wild-type level by the multiple mutations in both DRBMs which abolished dsRNA binding and dimerization (Fig. 5) . These data strongly suggest that phosphorylation of Thr-451 is stimulated by dsRNA binding. Additional evidence for this conclusion came from our finding that Thr-451 could be phosphorylated in vitro by PKR immunopurified from HeLa cells, provided that the cells were pretreated with dsRNA. Presumably dsRNA treatment induced autophosphorylation of Thr-451 in vivo, but the pT451 was eliminated by a protein phosphatase before or during immunopurification of the enzyme. We also observed autophosphorylation of Thr-451 by highly purified PKR, dependent on dsRNA treatment and immunoprecipitation of the enzyme. The immunoprecipitation of PKR may have removed a copurifying phosphatase; alternatively, binding of PKR to antibodies may promote irreversible dimerization that maintains a high level of Thr-451 phosphorylation in the presence of phosphatase activity. The relative ease of detecting pT451 in yeast cells (without immunoprecipitation of PKR) may reflect the absence of a pT451 phosphatase activity or a higher level of dimerization produced by naturally occurring dsRNAs in this organism, compared with treatment of HeLa cells or purified enzyme with poly(I-C). Taken together, our findings support the idea that binding of PKR to dsRNA increases autophosphorylation in the activation loop of the kinase domain (Fig. 9) . Because dsRNA binding promotes dimerization, this would facilitate trans-autophosphorylation of Thr-446 and Thr-451 by the two kinase moieties in a PKR dimer (29, 30) . In addition, dimerization of the kinase domains seems to be required for efficient substrate phosphorylation by PKR (6, 23). As described above, dsRNA binding may also produce a conformational change that releases DRBM-II from inhibitory interactions with the kinase domain (Fig. 9) . This rearrangement could overcome a negative effect of DRBM-II on autophosphorylation of Thr-446 and Thr-451 in the activation loop. Based on studies of other kinases, autophosphorylation in the activation loop would promote proper alignment of key catalytic residues, or the correct orientation of the two lobes of the PKR kinase domain, required for substrate binding or phosphoryl transfer (51) (52) (53) (54) .
With this model, how can we explain the fact that Thr-451 was still autophosphorylated, albeit at reduced levels, by mutant proteins like FL-PKR-3AIϩ3AII which cannot bind dsRNA or form stable dimers? One possibility is that unstable PKR dimers can form transiently in the absence of dsRNA binding and persist long enough for intermolecular autophosphorylation to occur at a reduced rate. Alternatively, low level intramolecular autophosphorylation of Thr-451 by PKR monomers may occur. This second mechanism could account for the relatively high level of pT451 found in the FL-PKR-A67E product (data not shown), which is severely impaired for dimerization. Thus, by reducing the negative effect of the DRBMs on kinase function, A67E may allow Thr-451 autophosphorylation to occur in the absence of dimerization. Even though pT451 can be generated by the A67E mutant, the autophosphorylated monomers still exhibit reduced eIF2␣ kinase activity (Table II) , FIG. 9 . Model for PKR activation by dsRNA-dependent dimerization and autophosphorylation. The inactive form of PKR is monomeric, and the kinase domain (two shaded shapes depicting the Nand C-terminal lobes) is maintained in an inactive state by physical interactions with DRBM-II. Binding of two PKR molecules to the same molecule of dsRNA leads to formation of stable dimers and dissociation of the inhibitory interaction between DRBM-II and the kinase domain. Protein-protein interactions between the kinase domains (including residues 244 -296), and possibly the DRBMs, of the two PKR subunits also stabilize the dimer. High level intermolecular autophosphorylation occurs at multiple sites between the DRBMs, in the linker between the DRBMs and kinase domain, within the large kinase domain insert, and in the activation loop. Only the last sites are crucial for activation of eIF2␣ phosphorylation when PKR is analyzed in yeast. For details, see "Discussion."
presumably because dimerization of the kinase domains is also required for efficient eIF2␣ phosphorylation (6) .
Autophosphorylation Sites in the Kinase Domain Insert Are Required for High Level PKR Function Only When Autophosphorylation in the Activation Loop Is Impaired-We and others (13) have shown that Ala substitutions of the phosphorylation sites located between the DRBMs had little or no effect on kinase activity when introduced into wild-type PKR or PKR-T446A. In contrast, we showed here that mutations replacing all of the phosphorylation sites in the kinase domain insert (10Ala) did significantly reduce PKR activity when combined with the T446A mutation. The additive effects of the 10Ala and T446A mutations suggest that Thr-446 and one or more autophosphorylation sites in the kinase domain insert make independent contributions to an activated conformation of the enzyme. No additional reduction in PKR function occurred when the 10Ala and 3Ala substitutions were combined with T446A in the PKR-20Ala,T446A allele, implying that the sites affected by 10Ala and 3Ala mutations promote PKR activity by the same mechanism.
The S83A, S88A, S89A, and T90A substitutions between the two DRBMs exacerbated the deleterious effect of the 3Ala substitutions on PKR function when the mutant proteins were expressed transiently in COS-1 cells, but not in yeast (13) . Presumably, the phosphorylation sites between the DRBMs promote PKR activation independently of Ser-242, Ser-255, and Thr-258 in a manner that depends on mammalian factors that are absent in yeast cells. Similarly, the autophosphorylation sites in the kinase domain insert may play a more important regulatory role in mammalian cells than in yeast, for example functioning as recognition sites for a protein phosphatase or kinase that modulates PKR activity independently of dsRNA.
